Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07793591

Veteran Centered Meal Intervention in Chronic Kidney Disease

This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned to receive either medically tailored meals or usual care (wait-list control) for 3 months, followed by follow-up/crossover period. The study will evaluate blood pressure, kidney health, diet, quality of life, and other health outcomes, as well as the feasibility and acceptability of providing medically tailored meals to Veterans with kidney disease.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This pilot randomized clinical trial will evaluate the feasibility, acceptability, and preliminary effects of medically tailored meals among Veterans with chronic kidney disease. Approximately 100 Veterans with stage 3b or 4 chronic kidney disease and elevated systolic blood pressure will be enrolled and randomized 1:1 to receive medically tailored meals or usual care during an initial 3-month intervention period. Participants initially assigned to usual care will subsequently receive medically tailored meals during a 3-month crossover period. All participants will be followed for 6 months.

The medically tailored meal intervention will provide prepared meals designed to support dietary recommendations for chronic kidney disease and cardiovascular health. The study will assess intervention feasibility and acceptability, including recruitment, adherence, retention, completion of study assessments, and participant experiences with the meals.

Clinical outcomes will include systolic blood pressure, kidney function and injury measures, cardiometabolic laboratory markers, and vascular function. Dietary intake and diet quality will be assessed using 24-hour dietary recalls. Patient-reported and behavioral outcomes will include kidney disease-related quality of life, general health and well-being, treatment burden, and measures related to dietary behavior and self-management. Healthcare utilization and medication use will also be evaluated. Assessments will generally occur at baseline, 3 months, and 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Veteran enrolled in the Veterans Health Administration
  • Stage 3b or stage 4 Chronic Kidney Disease (CKD) ((estimated glomerular filtration rate (eGFR) 15-44 milliliter (mL)/minute/1.73 square meter (m²))
  • Systolic blood pressure 140-160 mmHg (millimeters of mercury); with a ± 5 mmHg tolerance range
  • Body mass index (BMI) between 18.5 and 40.0 kilogram (kg)/square meter (m²)
  • Able and willing to provide informed consent
  • Able and willing to participate in study visits and study procedures
  • Able to receive medically tailored meal deliveries within the study service area

Exclusion criteria

  • Inability to communicate in English or severe hearing impairment either, preventing study participation
  • Participation in a medically tailored meal program within the previous 6 months
  • Diagnosis of heart failure
  • Major active gastrointestinal disorder that would interfere with participation or nutritional management
  • Active cancer treatment (chemotherapy) or anticipated treatment within the next 12 months
  • Pregnancy
  • Current homelessness preventing meal delivery
  • Active substance use disorder not in remission
  • Active psychosis or another condition that would impair participation
  • Terminal illness or life expectancy less than 12 months
  • Any other medical, psychiatric, or social condition that, in the opinion of the investigators, would make participation unsafe or interfere with completion of the study

Treatment and study plan

Medically Tailored Meals (MTMs)

Other

Medically tailored meals are prepared to support dietary recommendations for chronic kidney disease and cardiovascular health while considering individual dietary needs and preferences. The intervention also included nutrition education and study-related dietary support.

Other names: MTM

Primary outcomes

  1. Systolic blood pressure (SBP)

    Time frame: 3 months

    Change in systolic blood pressure (SBP), measured in mmHg, from baseline to the 3-month assessment.

Secondary outcomes

  1. Urine albumin-to-creatinine ratio (UACR)

    Time frame: 3 months

    Change in urine albumin-to-creatinine ratio (UACR; milligrams/gram) from baseline to 3 months, measured using urine laboratory testing through the VA clinical laboratory.

  2. Estimated glomerular filtration rate (eGFR)

    Time frame: 3 months

    Change in estimated glomerular filtration rate (eGFR; milliliter/minute/1.73^square meter) from baseline to 3 months, based on serum creatinine OR cystatin C, measured through the VA clinical laboratory.

Other outcomes

  1. Diet quality and intake

    Time frame: 3 months, 6 months

    Change in Healthy Eating Index score from baseline to 3 and 6 months, calculated from dietary nutrient intake assessed using the Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24).

  2. Kidney Disease-Related Quality of Life

    Time frame: 3 months, 6 months

    Health-related quality of life will be assessed using the Kidney Disease Quality of Life-36 (KDQOL-36), a validated kidney disease-specific instrument. Results will be reported as KDQOL-36 scores, with higher scores indicating better health-related quality of life.

  3. Medically Tailored Meal Adherence

    Time frame: 3 months, 6 months

    Adherence to the medically tailored meal intervention will be assessed using structured weekly participant check-ins. Adherence will be calculated as the number of provided meals consumed divided by the number of meals provided, multiplied by 100, and reported as percent of meals consumed (%).

Study contacts

Contact information is provided by the study sponsor or research team.

Luis M Perez, PhD RD

CONTACT

[email protected]

(720) 467-0757

Maryam I Nuriyeva, MPH

CONTACT

[email protected]

(720) 857-2712

Sponsors and collaborators

Lead sponsor

VA Office of Research and Development

Fed

Registry information

Official study title

A Veteran-Centered Medically Tailored Meal Intervention to Improve Clinical and Patient Reported Outcomes in Chronic Kidney Disease (VETCKD)

Acronym: VETCKD

Important dates

Study start
2027
Primary completion
2030
Study completion
2030
First posted
Aug 28, 2026
Registry last updated
Sep 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.